These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
238 related articles for article (PubMed ID: 20112163)
1. West Nile Virus: is a vaccine needed? Martina BE; Koraka P; Osterhaus AD Curr Opin Investig Drugs; 2010 Feb; 11(2):139-46. PubMed ID: 20112163 [TBL] [Abstract][Full Text] [Related]
2. Safety of an attenuated West Nile virus vaccine, live Flavivirus chimera in horses. Long MT; Gibbs EP; Mellencamp MW; Zhang S; Barnett DC; Seino KK; Beachboard SE; Humphrey PP Equine Vet J; 2007 Nov; 39(6):486-90. PubMed ID: 18065304 [TBL] [Abstract][Full Text] [Related]
3. Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model. Long MT; Gibbs EP; Mellencamp MW; Bowen RA; Seino KK; Zhang S; Beachboard SE; Humphrey PP Equine Vet J; 2007 Nov; 39(6):491-7. PubMed ID: 18065305 [TBL] [Abstract][Full Text] [Related]
4. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse. El Garch H; Minke JM; Rehder J; Richard S; Edlund Toulemonde C; Dinic S; Andreoni C; Audonnet JC; Nordgren R; Juillard V Vet Immunol Immunopathol; 2008 Jun; 123(3-4):230-9. PubMed ID: 18372050 [TBL] [Abstract][Full Text] [Related]
5. A case-control study of factors associated with development of clinical disease due to West Nile virus, Saskatchewan 2003. Epp T; Waldner C; Townsend HG Equine Vet J; 2007 Nov; 39(6):498-503. PubMed ID: 18065306 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses. Siger L; Bowen R; Karaca K; Murray M; Jagannatha S; Echols B; Nordgren R; Minke JM Vet Ther; 2006; 7(3):249-56. PubMed ID: 17039448 [TBL] [Abstract][Full Text] [Related]
7. Protection provided by a recombinant ALVAC(®)-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain. Minke JM; Siger L; Cupillard L; Powers B; Bakonyi T; Boyum S; Nowotny N; Bowen R Vaccine; 2011 Jun; 29(28):4608-12. PubMed ID: 21549780 [TBL] [Abstract][Full Text] [Related]
8. The anamnestic serologic response to vaccination with a canarypox virus-vectored recombinant West Nile virus (WNV) vaccine in horses previously vaccinated with an inactivated WNV vaccine. Grosenbaugh DA; Backus CS; Karaca K; Minke JM; Nordgren RM Vet Ther; 2004; 5(4):251-7. PubMed ID: 15719324 [TBL] [Abstract][Full Text] [Related]
9. Safety and efficacy in geese of a PER.C6-based inactivated West Nile virus vaccine. Samina I; Havenga M; Koudstaal W; Khinich Y; Koldijk M; Malkinson M; Simanov M; Perl S; Gijsbers L; Weverling GJ; Uytdehaag F; Goudsmit J Vaccine; 2007 Nov; 25(49):8338-45. PubMed ID: 17977629 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of Cross-Protection of a Lineage 1 West Nile Virus Inactivated Vaccine against Natural Infections from a Virulent Lineage 2 Strain in Horses, under Field Conditions. Chaintoutis SC; Diakakis N; Papanastassopoulou M; Banos G; Dovas CI Clin Vaccine Immunol; 2015 Sep; 22(9):1040-9. PubMed ID: 26178384 [TBL] [Abstract][Full Text] [Related]
11. Comparative efficacies of three commercially available vaccines against West Nile Virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model. Seino KK; Long MT; Gibbs EP; Bowen RA; Beachboard SE; Humphrey PP; Dixon MA; Bourgeois MA Clin Vaccine Immunol; 2007 Nov; 14(11):1465-71. PubMed ID: 17687109 [TBL] [Abstract][Full Text] [Related]
12. Characteristics of an outbreak of West Nile virus encephalomyelitis in a previously uninfected population of horses. Ward MP; Schuermann JA; Highfield LD; Murray KO Vet Microbiol; 2006 Dec; 118(3-4):255-9. PubMed ID: 16971067 [TBL] [Abstract][Full Text] [Related]
13. High subclinical West Nile virus incidence among nonvaccinated horses in northern California associated with low vector abundance and infection. Nielsen CF; Reisen WK; Armijos MV; Maclachlan NJ; Scott TW Am J Trop Med Hyg; 2008 Jan; 78(1):45-52. PubMed ID: 18187784 [TBL] [Abstract][Full Text] [Related]
14. West Nile virus infection of horses. Castillo-Olivares J; Wood J Vet Res; 2004; 35(4):467-83. PubMed ID: 15236677 [TBL] [Abstract][Full Text] [Related]
15. Equine vaccine for West Nile virus. Ng T; Hathaway D; Jennings N; Champ D; Chiang YW; Chu HJ Dev Biol (Basel); 2003; 114():221-7. PubMed ID: 14677692 [TBL] [Abstract][Full Text] [Related]
16. West Nile virus activity--United States, 2006. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2007 Jun; 56(22):556-9. PubMed ID: 17557072 [TBL] [Abstract][Full Text] [Related]
17. West Nile virus activity--United States, 2007. Centers for Disease Control and Prevention (CDC) MMWR Morb Mortal Wkly Rep; 2008 Jul; 57(26):720-3. PubMed ID: 18600197 [TBL] [Abstract][Full Text] [Related]
18. West Nile virus: recent trends in diagnosis and vaccine development. Dauphin G; Zientara S Vaccine; 2007 Jul; 25(30):5563-76. PubMed ID: 17292514 [TBL] [Abstract][Full Text] [Related]
19. West Nile virus in the United States (1999-2005). Gerhardt R J Am Anim Hosp Assoc; 2006; 42(3):170-7. PubMed ID: 16611928 [TBL] [Abstract][Full Text] [Related]
20. Investigation of antigen specific lymphocyte responses in healthy horses vaccinated with an inactivated West Nile virus vaccine. Davis EG; Zhang Y; Tuttle J; Hankins K; Wilkerson M Vet Immunol Immunopathol; 2008 Dec; 126(3-4):293-301. PubMed ID: 18838173 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]